Join Millennium Science for an engaging seminar presented by Dr Rob Burgess where we explore how advances in recombinant enzyme technology and bioactive kinase platforms are enabling precise investigation of signalling networks.
Drawing on the enzyme portfolio originally developed by SignalChem Biotech and now part of Sino Biological, Dr Burgess will highlight how high-quality bioactive proteins support both basic and translational research.
Key topics include:
•Kinase signalling and phosphorylation pathways in cell growth and immune activation
• Ubiquitin systems regulating protein turnover and stress responses
• Epigenetic enzymes controlling gene expression
• Kinase inhibitor screening for therapeutic discovery
• Mechanistic insights into cancer, immunology, and neurodegeneration
Dr Burgess will also show how bioactive enzyme platforms can accelerate target discovery and advance disease-focused research.